Eagle Asset Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
|
|||||
2024
Q2 | $7.12M | Sell |
|
|||||
2024
Q1 | $11.1M | Buy |
|
|||||
2023
Q4 | $13M | Buy |
|
|||||
2023
Q3 | $10.9M | Buy |
|
|||||
2023
Q2 | $11.3M | Buy |
|
|||||
2023
Q1 | $12.5M | Buy |
|
|||||
2022
Q4 | $7.59M | Sell |
|
|||||
2022
Q3 | $5.88M | Buy |
|
|||||
2022
Q2 | $5.06M | Sell |
|
|||||
2022
Q1 | $6.04M | Sell |
|
|||||
2021
Q4 | $6.8M | Sell |
|
|||||
2021
Q3 | $16.4M | Sell |
|
|||||
2021
Q2 | $20.8M | Buy |
|
|||||
2021
Q1 | $20.6M | Buy |
|
|||||
2020
Q4 | $17.8M | Sell |
|
|||||
2020
Q3 | $16.2M | Buy |
|
|||||
2020
Q2 | $15.6M | Buy |
|
|||||
2020
Q1 | $13.4M | Buy |
|
|||||
2019
Q4 | $15.1M | Buy |
|
|||||
2019
Q3 | $13.1M | Sell |
|
|||||
2019
Q2 | $12.4M | Sell |
|
|||||
2019
Q1 | $12.6M | Buy |
|
|||||
2018
Q4 | $10.1M | Buy |
|
|||||
2018
Q3 | $14.2M | Buy |
|
|||||
2018
Q2 | $10.9M | Buy |
|
|||||
2018
Q1 | $8.94M | Sell |
|
|||||
2017
Q4 | $7.89M | Buy |
|
|||||
2017
Q3 | $8.16M | Sell |
|
|||||
2017
Q2 | $89.8M | Buy |
|
|||||
2017
Q1 | $49.9M | Buy |
|
|||||
2016
Q4 | $42.7M | Buy |
|
|||||
2016
Q3 | $4.89M | Sell |
|
|||||
2016
Q2 | $5.87M | Buy |
|
|||||
2016
Q1 | $4.78M | Sell |
|
|||||
2015
Q4 | $5.76M | Sell |
|
|||||
2015
Q3 | $5.25M | Sell |
|
|||||
2015
Q2 | $5.99M | Buy |
|
|||||
2015
Q1 | $3.16M | Sell |
|
|||||
2014
Q4 | $3.13M | Sell |
|
|||||
2014
Q3 | $3.46M | Sell |
|
|||||
2014
Q2 | $3.31M | Sell |
|
|||||
2014
Q1 | $3.33M | Sell |
|
|||||
2013
Q4 | $4.39M | Sell |
|
|||||
2013
Q3 | $3.69M | Sell |
|
|||||
2013
Q2 | $3.42M | Buy |
|